Erratum to: Autoradiography, MALDI-MS, and SIMS-MS Imaging in Pharmaceutical Discovery and Development
Journal Title: The AAPS Journal - Year 2010, Vol 12, Issue 1
Abstract
This article was published with incorrect reference citations in the permission notes in the legends for Figures  8 and 9. The permission note for Figure 8 should read: (Adapted with permission from Ref. 84). The permission note for Figure 9 should read: (Adapted with permission from Ref. 85).
Authors and Affiliations
Eric G. Solon, Alain Schweitzer, Markus Stoeckli, Brendan Prideaux
Keywords
Related Articles
- EP ID EP681364
- DOI 10.1208/s12248-009-9167-3
- Views 82
- Downloads 0
Bladder Tissue Pharmacokinetics of Intravesical Mitomycin C and Suramin in Dogs
Suramin, at non-cytotoxic doses, reverses chemoresistance and enhances the activity of mitomycin C (MMC) in mice bearing human bladder xenograft tumors. The present study evaluated the pharmacokinetics of the intravesica...
Quantitative comparison of functional screening by measuring intracellular Ca2+ with radioligand binding at recombinant human dopamine receptors
The purpose of this study was to test whether screening at dopamine receptors performed with a recently described functional assay for G-protein coupled receptors (GPCRs) provides data that correlate significantly with r...
Human Health Relevance of Pharmaceutically Active Compounds in Drinking Water
The online version of this article (doi:10.1208/s12248-015-9729-5) contains supplementary material, which is available to authorized users.
Understanding Pharmaceutical Quality by Design
This review further clarifies the concept of pharmaceutical quality by design (QbD) and describes its objectives. QbD elements include the following: (1) a quality target product profile (QTPP) that identifies the critic...
Addressing the Challenges of Low Clearance in Drug Research
As a result of high-throughput ADME screening, early metabolite identification, and exploration of novel chemical entities, low-intrinsic-clearance compounds continue to increase in drug discovery portfolios. Currently a...